{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:38:14Z","timestamp":1793831894931,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023QNRC001"],"award-info":[{"award-number":["2023QNRC001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472765"],"award-info":[{"award-number":["82472765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81988101"],"award-info":[{"award-number":["81988101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902940"],"award-info":[{"award-number":["81902940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303070"],"award-info":[{"award-number":["82303070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172896"],"award-info":[{"award-number":["82172896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91859205"],"award-info":[{"award-number":["91859205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830054"],"award-info":[{"award-number":["81830054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007054","name":"Second Military Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.143246","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T11:45:11Z","timestamp":1744803911000},"page":"143246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"P4","title":["Circular RNA CDYL facilitates hepatocellular carcinoma stemness and PD-L1+ exosomes-mediated immunotherapy resistance via stabilizing hornerin protein by blocking synoviolin 1-mediated ubiquitination"],"prefix":"10.1016","volume":"310","author":[{"given":"Jingbo","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihua","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijbiomac.2025.143246_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2025.143246_bb0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0030-1247133","article-title":"Current strategy for staging and treatment: the BCLC update and future prospects","volume":"30","author":"Forner","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ijbiomac.2025.143246_bb0015","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.143246_bb0020","unstructured":"Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection."},{"issue":"223\u201343","key":"10.1016\/j.ijbiomac.2025.143246_bb0025","first-page":"vii","article-title":"The global epidemiology of hepatocellular carcinoma: present and future","volume":"15","author":"McGlynn","year":"2011","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ijbiomac.2025.143246_bb0030","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"issue":"7680","key":"10.1016\/j.ijbiomac.2025.143246_bb0035","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"issue":"3_suppl","key":"10.1016\/j.ijbiomac.2025.143246_bb0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1200\/JCO.2021.39.3_suppl.335","article-title":"Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC)","volume":"39","author":"Yarchoan","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143246_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jamaoncol.2020.3381","article-title":"The current landscape of immune checkpoint blockade in hepatocellular carcinoma: a review","volume":"7","author":"Pinter","year":"2021","journal-title":"JAMA Oncol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.143246_bb0050","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.143246_bb0055","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143246_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-cellbio-120420-125117","article-title":"Biogenesis and regulatory roles of circular RNAs","volume":"38","author":"Yang","year":"2022","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143246_bb0065","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.30795","article-title":"A noncoding regulatory RNAs network driven by Circ-CDYL acts specifically in the early stages hepatocellular carcinoma","volume":"71","author":"Wei","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143246_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41575-021-00508-3","article-title":"Cancer stem cells in hepatocellular carcinoma \u2013 from origin to clinical implications","volume":"19","author":"Lee","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.143246_bb0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2013-305715","article-title":"Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein4","volume":"64","author":"Li","year":"2015","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.143246_bb0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.143246_bb0085","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Th\u00e9ry","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.143246_bb0090","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/s41401-023-01079-6","article-title":"Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors","volume":"44","author":"Kovacs","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2025.143246_bb0095","doi-asserted-by":"crossref","unstructured":"Fu SJ, Shen SL, Li SQ, Hua YP, Hu WJ, Guo B, Peng BG. Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma. BMC Cancer 2018 Aug13;18(1):815.","DOI":"10.1186\/s12885-018-4719-5"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143246_bb0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41392-021-00801-2","article-title":"An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity","volume":"6","author":"Wei","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.143246_bb0105","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143246_bb0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12943-021-01485-6","article-title":"EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3","volume":"21","author":"Pan","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143246_bb0115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41467-017-00299-9","article-title":"An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.143246_bb0120","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/jcmm.16180","article-title":"Ubiquitously specific protease 4 inhibitor-Vialinin a attenuates inflammation and fibrosis in S100-induced hepatitis mice through Rheb\/mTOR signalling","volume":"25","author":"Xu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.143246_bb0125","doi-asserted-by":"crossref","unstructured":"Granatiero V, Sayles NM, Savino AM, Konrad C, Kharas MG, Kawamata H, Manfredi G. Modulation of the IGF1R-MTOR pathway attenuates motor neuron toxicity of human ALS SOD1G93A astrocytes. Autophagy. 2021Dec;17(12):4029\u20134042.","DOI":"10.1080\/15548627.2021.1899682"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.143246_bb0130","article-title":"S100A10 accelerates aerobic glycolysis and malignant growth by activating mTOR-signaling pathway in gastric Cancer","volume":"26","author":"Li","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143246_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/intimm\/dxu095","article-title":"Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies","volume":"27","author":"Philips","year":"2015","journal-title":"Int. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.143246_bb0140","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/cac2.12327","article-title":"KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1\/PD-L1 immunotherapy in non-small cell lung cancer","volume":"42","author":"Liu","year":"2022","journal-title":"Cancer Commun (Lond)."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.143246_bb0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-14-3362","article-title":"Control of PD-L1 expression by oncogenic activation of the AKT-mTOR pathway in non-small cell lung Cancer","volume":"76","author":"Lastwika","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143246_bb0150","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/s41467-023-38232-y","article-title":"Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy","volume":"14","author":"Dong","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.143246_bb0155","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/nar\/gkw027","article-title":"Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2","volume":"44","author":"Du","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143246_bb0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","article-title":"Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output","volume":"183","author":"Zhao","year":"2020","journal-title":"Cell"},{"issue":"8005","key":"10.1016\/j.ijbiomac.2025.143246_bb0165","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41586-024-07112-w","article-title":"The CRL5-SPSB3 ubiquitin ligase targets nuclear cGAS for degradation","volume":"627","author":"Xu","year":"2024","journal-title":"Nature"},{"issue":"7528","key":"10.1016\/j.ijbiomac.2025.143246_bb0170","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"issue":"7718","key":"10.1016\/j.ijbiomac.2025.143246_bb0175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025037985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025037985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:54:28Z","timestamp":1782903268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025037985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":35,"alternative-id":["S0141813025037985"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143246","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circular RNA CDYL facilitates hepatocellular carcinoma stemness and PD-L1+ exosomes-mediated immunotherapy resistance via stabilizing hornerin protein by blocking synoviolin 1-mediated ubiquitination","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"143246"}}